Europe — EMA
Onaka (Pidotimod)
GNH USA supplies Onaka (Pidotimod), an immunostimulant for preventing recurrent respiratory infections and supporting immunity. Request a quote for supply.
Request sourcing
What is Pidotimod?
Pidotimod, the active ingredient in Onaka, is an immunostimulant presented as an oral formulation for oral use. It is used to prevent and treat recurrent respiratory tract infections and to support immune function in immunocompromised patients.
GNH USA supplies Onaka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Pidotimod used for?
Onaka, an immunostimulant, acts on the respiratory infection pathway and immune modulation. - Recurrent respiratory tract infections: reduces frequency and severity of infections. - Immunocompromised patients: supports overall immune function. - Children with frequent infections: helps prevent respiratory infections.
What are the side effects of Pidotimod?
Adverse reactions may occur with any immunomodulatory therapy.
Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, usually transient. - Abdominal pain: discomfort in the stomach area. - Headache: mild to moderate intensity. - Rash: mild skin erythema or itching. - Low‑grade fever: mild temperature elevation.
Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Stevens‑Johnson syndrome: rare severe skin reaction. - Hepatic dysfunction: abnormal liver enzymes or hepatitis. - Severe neutropenia: marked reduction in neutrophil count. - Autoimmune phenomena: emergence of autoimmune disorders. - Severe gastrointestinal bleeding: uncommon but serious.
What precautions apply to Pidotimod?
Before prescribing Onaka, consider patient‑specific factors and safety measures. - Pregnancy: safety not established; use only if benefits outweigh risks. - Breastfeeding: caution advised; monitor infant for adverse effects. - Renal impairment: assess renal function and adjust therapy if needed. - Hepatic impairment: monitor liver function during treatment. - Concomitant immunosuppressants: may diminish therapeutic effect; monitor immune status. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.
What does Pidotimod interact with?
Onaka may interact with other medicines; review patient medication list.
Major Interactions (Avoid): - Live vaccines: concurrent use may reduce vaccine efficacy. - Strong immunosuppressive agents: may blunt immunostimulatory effect.
Moderate Interactions (Monitor Closely): - Antibiotics: possible alteration of gut flora affecting immunity. - Antifungal agents: may influence immune response. - Corticosteroids: could counteract immunostimulant action. - Other immunomodulators: additive effects require careful monitoring.


